Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

460

Participants

Timeline

Start Date

July 1, 2005

Primary Completion Date

August 18, 2006

Study Completion Date

September 16, 2006

Conditions

Schizophrenia

Interventions

DRUG

Asenapine

5 mg BID

DRUG

Asenapine

10 mg BID

DRUG

Haloperidol

4 mg BID

OTHER

Placebo arm

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00156104 - Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) | Biotech Hunter | Biotech Hunter